Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Linda M. H. van de Winkel"'
Autor:
Marissa Meegdes, Khava I. E. Ibragimova, Dorien J. A. Lobbezoo, Ingeborg J. H. Vriens, Loes F. S. Kooreman, Frans L. G. Erdkamp, M. Wouter Dercksen, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Manon J. A. E. Pepels, Linda M. H. van de Winkel, Jolien Tol, Joan B. Heijns, Agnes J. van de Wouw, Natascha A. J. B. Peters, Ananda Hochstenbach-Waelen, Marjolein L. Smidt, Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen
Publikováno v:
Breast Cancer Research and Treatment, 192(2), 331-342. Springer, Cham
Purpose The hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) are the main parameters in guiding systemic treatment choices in breast cancer, but can change during the disease course. This study aims to evaluate the biopsy rat
Autor:
Marissa, Meegdes, Sandra M E, Geurts, Frans L G, Erdkamp, Marcus Wouter, Dercksen, Birgit E P J, Vriens, Kirsten N A, Aaldering, Manon J A E, Pepels, Linda M H, van de Winkel, Nathalie J A, Teeuwen, Maaike, de Boer, Vivianne C G, Tjan-Heijnen
Publikováno v:
International journal of cancer. 150(1)
In August 2017, cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy have been reimbursed in the Netherlands for patients with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer (ABC). This study